One such person is Chirayu Amin, an Indian billionaire businessman, cricket administrator and also a pharma tycoon. He ...

As President-elect Trump prepares for his second term in office, the health care industry is poised for a period of potential ...

Private equity firms Carlyle Group Inc.’s AlpInvest and Sixth Street are backing Essential Pharma as part of a €900 million ($945 million) recapitalization of the drugmaker.

“Partnerships between academia and industry foster innovation, especially in niche areas like therapeutics, biologics, gene ...

Biden Administration Extends COVID-19 Emergency Declaration Until 2029** In a shocking maneuver that has stirred concerns among critics, the Biden administration has extended the controversial ...

Google's Willow chip reduces errors exponentially, addressing a problem the industry has faced for almost 30 years.

Following a downturn in M&A in 2024, the pharma and life sciences industry can expect to see a busier year in 2025.

Vertex Pharmaceuticals Incorporated looks set for two new drug approvals in early 2025. Click here to read an analysis of ...

By far, the largest acquisition of 2024 was Novo Holdings' yet-to-be-closed buyout of manufacturer Catalent at $16.5 billion.

President-elect Donald Trump selects Andrew Ferguson as FTC chair, promising to end Big Tech censorship and protect freedom of speech.